Journey Medical Corporation (DERM) NASDAQ
5.89
-0.2(-3.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.89
-0.2(-3.28%)
Currency In USD
| Market Cap | 188.88M |
| Enterprise Value | 164.91M |
| P/E Ratio | -16.77 |
| PEG Ratio | 1.51 |
| Price/Sales Ratio | 2.51 |
| Price/Book Ratio | 5.22 |
| Enterprise/Revenue | 2.48 |
| Enterprise/EBITDA | -88.99 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.15 |
| Operating Margin | -0.1 |
| Return On Assets | -0.1 |
| Return On Equity | -0.36 |
| Revenue | 61.86M |
| Revenue/Share | 2.37 |
| Gross Profit | 36.68M |
| EBITDA | -3.83M |
| Net Income | -11.43M |
| Diluted EPS | -0.47 |
| Total Cash | 27.22M |
| Total Cash/Share | 1 |
| Total Debt | 25.47M |
| Total Debt/Equity | 0.83 |
| Current Ratio | 1.72 |
| Book Value Per Share | 1.13 |
| 52-Week Change | -24.58 |
| 52-Week High | 9.56 |
| 52-Week Low | 4.31 |
| Moving Average 50 Days | 5.47 |
| Moving Average 200 Days | 7.2 |
| Average Volume | 262,334 |
| Shares Outstanding | 27.52M |
| % Held by Institutions | 48.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |